Comparative analysis of tumor-infiltrating lymphocytes in a syngeneic mouse model of oral cancer.

mTOR and MEK1/2 inhibition differentially modulate tumor growth and the immune microenvironment in syngeneic models of oral cavity cancer. Oncotarget (2015) 0.87

Enhanced Tumor Control with Combination mTOR and PD-L1 Inhibition in Syngeneic Oral Cavity Cancers. Cancer Immunol Res (2016) 0.77

Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature (2012) 7.76

A critical function for type I interferons in cancer immunoediting. Nat Immunol (2005) 4.14

Pulsed high-intensity focused ultrasound enhances apoptosis and growth inhibition of squamous cell carcinoma xenografts with proteasome inhibitor bortezomib. Radiology (2008) 1.82

Comparative analysis of regulatory and effector T cells in progressively growing versus rejecting tumors of similar origins. Cancer Res (2006) 1.39

IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation. J Immunol (2002) 1.36

ERK1/2 regulation of CD44 modulates oral cancer aggressiveness. Cancer Res (2011) 1.34

Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligands. Cancer Res (2010) 1.31

TNF-α promotes c-REL/ΔNp63α interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancer. Cancer Res (2011) 1.20

Proteomic signatures of epidermal growth factor receptor and survival signal pathways correspond to gefitinib sensitivity in head and neck cancer. Clin Cancer Res (2009) 1.17

Molecular and clinical responses in a pilot study of gefitinib with paclitaxel and radiation in locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys (2009) 0.89

The clinical implications of antitumor immunity in head and neck cancer. Laryngoscope (2012) 0.89

Identifying the initiating events of anti-Listeria responses using mice with conditional loss of IFN-γ receptor subunit 1 (IFNGR1). J Immunol (2013) 0.88

CXCR3 enhances a T-cell-dependent epidermal proliferative response and promotes skin tumorigenesis. Cancer Res (2011) 0.88

Emerging insights into head and neck cancer metastasis. Head Neck (2012) 0.86

Association of reflux with otitis media in children. Otolaryngol Head Neck Surg (2005) 0.84

Spontaneous regression of cutaneous head and neck melanoma: implications for the immunologic control of neoplasia. Head Neck (2008) 0.83

Mycotic pseudoaneurysm of the internal maxillary artery: case report and review of the literature. Arch Otolaryngol Head Neck Surg (2007) 0.79

Novel application of the palatal island flap for endoscopic skull base reconstruction. Laryngoscope (2009) 0.78

Endoscopic surgical management of vidian nerve schwannoma. Laryngoscope (2011) 0.78

Combined high-field intraoperative magnetic resonance imaging and endoscopy increase extent of resection and progression-free survival for pituitary adenomas. Pituitary (2015) 0.77

Oral hairy leukoplakia in an HIV-negative patient. Ear Nose Throat J (2013) 0.75

Pathology quiz case 2. Rhabdomyoma, adult type. Arch Otolaryngol Head Neck Surg (2009) 0.75

Pathology quiz case 2. Atypical meningioma with clear cell features (World Health Organization [WHO] grade II). Arch Otolaryngol Head Neck Surg (2008) 0.75

Juvenile xanthogranuloma of supra-sellar region: a rare presentation. Clin Neuropathol (2015) 0.75

Prevalence of diabetes mellitus and its impact on disease severity in adult recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg (2013) 0.75